Comment related to the publication “Elevation of transaminases after MMP® session with methotrexate for alopecia areata treatment ‒ How much do we know about the risks of systemic absorption of the technique?” ‒ Answer
Renata Heck, Renan Rangel Bonamigo

Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsHuman Rights and Immigration · Labor Law and Work Dynamics · European Criminal Justice and Data Protection
Dear Editor,
We agree with the consideration that, regarding the cause of the increase in transaminase levels in the described patient, there are no means of affirming with certainty the association with the MMP® technique.1 We reinforce, however, that she had already shown an elevation of transaminase levels with the previous use of the medication when administered orally. We attributed it to the technique used after excluding other possible causes such as infections, alcohol consumption, physical activity, or use of any other medication, in addition to the transitoriness of transaminitis in relation to the procedure.
The technique involves the penetration of needles into the dermis,2, 3 where vascularization is prominent in the scalp, with biological plausibility in affirming the possibility of absorption of the drug used. Additionally the patient is likely to be susceptible to methotrexate-related adverse effects, despite the small, absorbed dose.
We reaffirm the importance of reporting unexpected adverse effects related to the recent use of percutaneous treatment techniques, aiming at patient safety through adequate monitoring.
Financial support
None declared.
Authors' contributions
Renan Rangel Bonamigo: Drafting and editing of the manuscript and critical review of important intellectual content; effective participation in research orientation; intellectual participation in the propaedeutic and/or therapeutic conduct of the studied cases; critical review of the literature; approval of the final version of the manuscript.
Renata Heck: Design and planning of the study; drafting and editing of the manuscript and critical review of important intellectual content; effective participation in research orientation; intellectual participation in the propaedeutic and/or therapeutic conduct of the studied cases; critical review of the literature; approval of the final version of the manuscript.
Conflicts of interest
None declared.
The reference list from the paper itself. Each links out to its DOI / PubMed record.
- 1Nogueira B.L.Bonamigo R.R.Heck R.Elevation of transaminases after MMP® session with methotrexate for alopecia areata treatment - how much do we know about the risks of systemic absorption of the technique?An Bras Dermatol 98202339039110.1016/j.abd.2021.01.01336581558 PMC 10173054 · doi ↗ · pubmed ↗
- 2Arbache S.de Mendonca M.T.Arbache S.T.Hirata S.H.Treatment of idiopathic guttate hypomelanosis with a tattoo device versus a handheld needle JAAD Int 3202114163440936610.1016/j.jdin.2021.01.005PMC 8362163 · doi ↗ · pubmed ↗
- 3Arbache S.Mattos E.C.Diniz M.F.Paiva P.Y.A.Roth D.Arbache S.T.How much medication is delivered in a novel drug delivery technique that uses a tattoo machine?Int J Dermatol 5820197507553082879810.1111/ijd.14408 · doi ↗ · pubmed ↗
